最近内地医药企业到港股上市的越来越多,曾经“屡战屡败”的中药饮片企业新荷花也蠢蠢欲动。4月3日,港交所披露,四川新荷花中药饮片有限公司递交招股说明书。这家公司因多次寻求在A股上市未果而出名,期间还被员工举报财务造假。此番冲击港股IPO,备受业界关注。四川新荷花成立于2001年,是中国第一家中药饮片GMP工厂,在招股说明书中自称中药饮片收入排名全国第二。中药饮片已经事实上开展了国家集采,新荷花在此...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.